Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CeriBell, Inc.

CeriBell, Inc. (CBLL) Stock Overview

Explore CeriBell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CBLL●NASDAQ
HealthcareMedical - Devices
$27.60
$1.01(3.80%)
U.S. Market opens in 15h 51m

CeriBell, Inc. (CBLL)

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio-13.64
EPS (TTM)$-1.76
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 Month$34.74
3 Months$32.68
1 Year Target$32.21

CBLL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CeriBell, Inc. (NASDAQ: CBLL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CeriBell, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CBLL on the NASDAQ shows an RSI of 56.20, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $32.21 for the NASDAQ listing.

Key metrics behind CeriBell, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.64 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CBLL on the NASDAQ.

Price Performance (NASDAQ: CBLL)

1-Day Change
3.80%
5-Day Change
25.17%
1-Month Change
16.80%
3-Month Change
46.73%
6-Month Change
36.63%
Year-to-Date (YTD) Change
25.85%
1-Year Change
134.30%
3-Year Change
10.40%
5-Year Change
10.40%
All-Time (Max) Change
10.40%

Contact Information

https://ceribell.com
800 436 0826
360 North Pastoria Avenue, Sunnyvale, CA, 94085

Company Facts

3,270 Employees
IPO DateOct 11, 2024
CountryUS
Actively Trading

Frequently Asked Questions